drugset / Trial / NCT04435782
A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to assess the effects of selexipag on right ventricular (RV) function in participants with Pulmonary arterial hypertension (PAH).
Timeline
- Start
- 2021-07-07
- Primary completion
- 2023-07-28
- Completion
- 2023-07-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Selexipag | Small molecule | 200 ug | — |